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Abstract
Background: Electronic health registries – eRegistries - can systematically collect relevant information at the point of
care for reproductive, maternal, newborn and child health (RMNCH). However, a suite of process and outcome
indicators is needed for RMNCH to monitor care and to ensure comparability between settings. Here we report on
the assessment of current global indicators and the development of a suite of indicators for the WHO Essential
Interventions for use at various levels of health care systems nationally and globally.
Methods: Currently available indicators from both household and facility surveys were collated through publicly
available global databases and respective survey instruments. We then developed a suite of potential indicators and
associated data points for the 45 WHO Essential Interventions spanning preconception to newborn care. Four types of
performance indicators were identified (where applicable): process (i.e. coverage) and outcome (i.e. impact) indicators
for both screening and treatment/prevention. Indicators were evaluated by an international expert panel against the
eRegistries indicator evaluation criteria and further refined based on feedback by the eRegistries technical team.
Results: Of the 45 WHO Essential Interventions, only 16 were addressed in any of the household survey data available.
A set of 216 potential indicators was developed. These indicators were generally evaluated favourably by the panel, but
difficulties in data ascertainment, including for outcome measures of cause-specific morbidity and mortality, were
frequently reported as barriers to the feasibility of indicators. Indicators were refined based on feedback, culminating in
the final list of 193 total unique indicators: 93 for preconception and antenatal care; 53 for childbirth and postpartum
care; and 47 for newborn and small and ill baby care.
Conclusions: Large gaps exist in the availability of information currently collected to support the implementation
of the WHO Essential Interventions. The development of this suite of indicators can be used to support the
implementation of eRegistries and other data platforms, to ensure that data are utilised to support evidence-based
practice, facilitate measurement and accountability, and improve maternal and child health outcomes.
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Background
Lack of quality data on the health status of individuals is a
major contributor to poor health outcomes at a population
level [1]. Progress towards the United Nations recently pro-
posed Sustainable Development Goals (SDGs) [2] can only
be monitored with efficient and effective health information
systems. Despite this obvious need, most low- and middle-
income countries (LMIC) have insufficient systems in place
for the collection, analysis and reporting of health data, se-
verely hampering both health system and policy-level
decision-making [3].
Improvement of data collection is ongoing in many
countries with the advent of electronic methods of data
collection, including electronic medical records to re-
place paper-based systems. The eRegistries Initiative
aims to support a safe and efficient transition to inte-
grated electronic health information systems in LMIC
[4, 5] (Frost M, Hodne Titlestad O, Lewis J, Mehl G,
Frøen JF: eRegistries: Architecture and Free Open Source
Software for maternal and child health Registries, submit-
ted). eRegistries should collect and manage information
that is adapted both to the health system’s information
needs, as well as the data collection and real-time analysis
methodology. Many existing indicators for monitoring
health have been designed and constructed to be reliably
measured from household and facility surveys [6, 7]; for
example, breastfeeding rates for children <6 months of
age. While these surveys are critical for national and
global monitoring needs [8], the historically weak data-
collection capabilities of LMIC [9, 10] render the utility of
such indicators limited in the context of the current global
transition to more robust health information systems.
Further, while these indicators are designed to guide
national policy level decisions and are collected through
relatively infrequent population surveys, improvement in
service delivery is not their primary aim. Similarly, many
facility-based surveys only include indicators to assess
readiness to deliver healthcare, leaving little attention
paid to quality of care. There are gaps in the specific in-
dicators needed to monitor and improve quality of care,
which are needed to supplement the existing facility
readiness and the population health indicators.
The Donabedian framework [11] describes three types
of indicators typically needed for monitoring the provision
of healthcare: structure, process and outcome. In this
framework, ‘structure’ refers to the assets needed to sup-
port health care, also known as ‘inputs’ and ‘outputs’ in
monitoring and evaluation frameworks [12], and include
access, supplies and personnel. Process indicators refer to
actions/activities performed during the delivery of health
care and may be known as coverage (or, as in monitoring
and evaluation frameworks, outcome) indicators. The
Donabedian framework uses ‘outcomes’ indicators to refer
to the endpoint of the individual health status, community
or population; these are often termed impact indicators by
monitoring and evaluation frameworks. ‘Bottleneck ana-
lyses’ consider six factors to assess how to change impact:
three structural (access, availability, training) and three
process (initial coverage, continued coverage, effective
coverage) indicators [13, 14]. Effective coverage indicators
attempt to include all aspects of quality within a single
final indicator that summarises the proportion of patients
receiving high-quality of care.
In this second paper of eRegistries series, we report on
indicators for use in monitoring the WHO Essential
Interventions Commodities and Guidelines for RMNCH
[15], which aim to improve quality of care and health
outcomes in reproductive, maternal and newborn care.
This component of the eRegistries Initiative had two
main aims:
1. to assess the status of global indicators by describing
the data that are currently available to address the
WHO Essential Interventions, and
2. to develop a robust suite of indicators and respective
data points to monitor WHO Essential Interventions –
both screening and management components – for
use in eRegistries.
We considered the 45 WHO Essential Interventions
delivered up to 6 weeks post-partum, including those
for: (1) preconception and periconceptual care; (2)
antenatal care; (3) childbirth care; (4) postpartum care
(of the mother); (5) immediate care of the newborn; (6)
neonatal infection management; and (7) care for small
and ill babies.
Methods
Assessment of the current status of global indicators
We first assessed the extent to which the 45 WHO
Essential Interventions [15] were being addressed in
either household or facility surveys, to better under-
stand the landscape of current data needs and gaps
that our indicator development project should ad-
dress. Our search focussed on the most recently re-
ported process and outcome indicators identified
from globally recognised sources. First, we examined
the common international databases which compile
indicators from various sources. These included the
Countdown to 2015 databases, UNICEF databases,
WHO observatory, and UNAIDS. These sources typ-
ically reported household surveys, primarily the large
scale multi-country initiatives of the Demographic
and Health Surveys (DHS) and Multiple Indicator
Cluster Survey (MICS). The DHS and MICS websites
were then assessed for additional information which
was not yet available in the large compilations already
mentioned. The average value for the most recent
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estimate of each indicator was calculated in Microsoft
Excel (Redmond, WA).
As household surveys are not designed for, nor capable
of, assessing process indicators relevant to care delivered
at facilities, we also assessed the availability of indicators
of key interventions directly from facility-based sources.
Eight survey instruments were identified which collected
data through either direct observations of patients or via
medical records review; we did not consider routine
health information systems as each country has their
own unique set of indicators that may or may not be
available in the public domain. Two published reviews
[16, 17] which identified available survey tools or instru-
ments were sourced. Surveys mentioned in these two
sources that did not focus on health, or were not used in
multiple LMIC, were excluded. In addition, to ensure
accuracy, two facility survey programs were directly
contacted for supplemental information. These facility
surveys have several purposes, one of which is to assess
the readiness of a facility to implement quality emer-
gency obstetric care. The survey instruments ultimately
included were: Service Provision Assessment (SPA)
(2012 version), Averting Maternal Death and Disability
(AMDD), the Maternal and Child Health Integrated
Program Quality of Care survey (MCHIP-QoC), the
Postpartum Hemorrhage Prevention and Treatment
questionnaire on Active Management of the third stage
of Labor (POPPHI), the World Bank’s Service Delivery
Indicators tool (SDI) (2012 Kenya version), WHOs
Service Availability and Readiness Assessment (SARA)
(version 2.1), as well as the WHO’s surveys on Perinatal
Health and on Maternal and newborn health from 2007
and 2010, respectively. All documents reviewed were the
most recent versions available in November 2014, unless
otherwise stated. One instrument included information
on management of post-partum haemorrhage and was
only included in our results as a denominator for rele-
vant interventions. Data were extracted from website
materials or survey instruments. Where information was
unavailable, survey support staff were interviewed to
identify the number of national facility surveys per-
formed for the specified interventions. For each inter-
vention, three domains related to process indicators
were assessed: training and knowledge, availability of
supplies (inventory), and whether the intervention was
actually performed. The number of survey instruments
collecting any information relevant to each of the 45
Essential Interventions in each of these three domains
was measured through careful reading of each survey
module.
Defining indicators and data points
For each of the 45 Essential Interventions, we conducted
a comprehensive search of existing WHO indicators,
followed by indicators from other professional bodies
(Table 1). Existing indicators were adapted or developed
as required by the eRegistries technical team with refer-
ence to the practice guidelines and training manuals
cited within each WHO Essential Intervention, and other
resources where appropriate.
Four types of indicators were defined for each WHO
intervention:
 process indicator/s for screening/risk identification
(the proportion of patients for whom screening
tests/risk identification measures were performed);
 outcome indicator/s for screening/risk identification
(the proportion of patients screening positive/
identified as ‘at-risk’);
 process indicator/s for treatment/management
(the proportion of patients treated); and
 outcome indicator/s for treatment/management
(the proportion of patients with adverse outcomes
in the population).
For some interventions, screening/risk assessment
indicators were not applicable. We considered screen-
ing/risk indicators not applicable where the given
treatment/management was recommended to all
women or babies of a given clearly defined population
(e.g. Antenatal care essential package for all pregnant
Table 1 Major sources for identifying existing indicators
WHO and UNAIDS indicators Other indicators
• The World Health Statistics 2011




•WHO Global Health Observatory
(http://apps.who.int/gho/data/#)
• Indicator registries relevant to
monitoring and evaluation for
specific Essential Interventions
(e.g. UNAIDS Indicator Registry:
http://www.indicatorregistry.org/)
• The World Health Organization’s
near-miss approach for maternal
health [29]
•Monitoring emergency obstetric
care: a handbook [30]
• Inter-agency Field Manual on
Reproductive Health in
Humanitarian Settings [31]
• Countdown to 2015 - Building a
Future for Women and Children
report [32]
• Indicators obtained from relevant
reports on monitoring and
evaluation of the specific intervention
(e.g., the ‘WHO World Malaria Report’)
found from general search of the
WHO website (http://www.who.int/en/)
• The official list of MDG
Indicators (mdgs.un.org)
• NICE menu of indicators:
(www.nice.org.uk/standards-
and-indicators)









• AHRQ National guidelines
clearinghouse (guideline.
gov/index.aspx)
• Royal College of Obstetricians
and Gynaecologists Guidelines
(www.rcog.org.uk/guidelines/)
Website links correct as at July 2015, we acknowledge links may be updated
in future
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women; Provision of thermal care for all newborns to
prevent hypothermia; Early initiation and exclusive
breastfeeding).
By data points we refer to the primary data being
captured at the point of care, which is the source of
information for numerator or denominator. Data
points that could be readily collected using an elec-
tronic form addressing each of the process and out-
come indicators were included. Data items specifically
measuring each indicator (numerator and denomin-
ator) were developed balancing specificity and feasibil-
ity by country resource level. To maximise the
feasibility of data collection, for defined conditions
such as preeclampsia, simple data points referring to
the diagnosis (yes/no) of the condition were accepted,
rather than delineated by the individual components
of the clinical and laboratory diagnosis.
Evaluation and refinement of indicators
Evaluation and refinement of the indicators occurred via
two stages: 1) Expert panel evaluation and; 2) Response to
feedback and refinement within the eRegistries technical
team.
Expert panel evaluation
An international group of 47 experts in maternal and child
health was assembled via the network of the International
Stillbirth Alliance. Thirty-four panel members were invited
to participate in consultation round 1; 35 in consultation
round 2; and 44 in consultation round 3. Invited evaluators
included researchers, senior clinicians and academics, ob-
stetricians, neonatologists, maternal-fetal medicine special-
ists, epidemiologists, consumer advocates and others.
The eRegistries indicator evaluation tool assessing 10
domains was developed. The domains were derived by
the eRegistries technical team after reviewing several
existing indicator evaluation frameworks, including the
New Economics Foundation AIMS criteria for indicators
[18, 19], the Agency for Healthcare Research and Quality
standards by which to judge quality indicator perform-
ance [20], Indicators to Monitor Maternal Health Goals
[21], and the SMART criteria [22]. The evaluation tool
(Additional file 1) was simplified based on pilot testing
with a subsample of the expert panel, culminating in the
final evaluation tool assessing the below five domains.
eRegistries indicator evaluation criteria:
 Action focused: “It is clear what needs to be done to
improve outcomes associated with this indicator
(e.g., immunised with tetanus toxoid to reduce
neonatal tetanus)”
 Important: “The indicator and the data generated will
make a relevant and significant contribution to
determining how to effectively respond to the problem”
 Operational: "The indicator is quantifiable;
definitions are precise and reference standards are
developed and tested or it is feasible to do so"
 Feasible: “It is feasible to collect data required for
indicator in the relevant setting”
 Simple and valued: “The people involved in the
service can understand and value indicator”
Panel members were asked to indicate via categorical
response their agreement with each of five statements
addressing the above domains (Yes/Probably/Unsure/
Possibly/No/Do not wish to respond). A comment box
was provided for each indicator to enable detailed feed-
back. Panel members were invited to suggest other indi-
cators or adjustments to the existing indicators. Data
were analysed descriptively in Microsoft Excel by tallying
the number of responses for each response category.
Indicators were evaluated in three consultation rounds:
(1) Preconception/periconceptual care and antenatal care;
(2) Childbirth care and postpartum care (of the mother)
and; (3) Immediate newborn care, neonatal infection
management, and care for small and ill babies. Additional
file 2 presents a list of interventions addressed, including
the number of indicators within each intervention, and
where the indicators were sourced. Panel members were
assigned 3 to 4 interventions in each round each and
asked to evaluate all indicators within the given interven-
tion. Interventions were assigned to evaluators randomly,
unless the panel member indicated a preference based on
their area of expertise.
For each intervention the panel members were given a
detailed breakdown of the indicators which included def-
initions, numerators and denominators, data points, and
references. An evidence summary for the interventions
was provided based on the evidence cited in the Essential
Interventions (predominantly Cochrane systematic re-
views). Panel members were given an evaluation sheet
along with a separate document containing background
information and evaluation instructions, including further
detail on the eRegistries indicator evaluation tool develop-
ment. Evaluation materials were sent to and returned by
panel members by email.
We adopted a quasi-anonymous approach for indica-
tor evaluation; that is, while individual panel members
may have known the names of other members in the
group, individual responses were not identifiable to the
group and panel members were not aware which inter-
ventions had been assigned for evaluation to whom.
Response to feedback and refinement within the eRegistries
technical team
Following descriptive analyses, indicators that consistently
failed to meet (or ‘probably’ meet) the defined criteria
were amended based on the evaluators’ comments, or else
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removed if deemed unnecessary for effective monitoring
and evaluation of the given intervention. A series of meet-
ings of the eRegistries technical team was held to review
the updated indicators to ensure consistency in nomencla-
ture across indicators and their data points, numerators
and denominators.
Graphical display of potential utilisation of the eRegistries
indicators
To inform the plausible utilisation of these indicators, a
power graph was created reflecting different use cases.
The power to detect a significant change in a given
indicator was graphed in association with the indicator
prevalence and a given sample size. Three scenarios of
different sample sizes were assumed: 200 births annually,
10,000 births annually and 500,000 births annually, to
reflect a typical rural clinic, a typical district and a
typical LMIC. The graphed indicator prevalence ranged
from 75 % to 0.01 %. The most likely value for each of
the indicators was calculated (Additional file 3) and
placed alongside the graph.
Results
Assessment of the current status of global indicators
Of the 45 WHO Essential Interventions, only 16 were
addressed in any of the household survey data avail-
able. Of these 16 interventions, only 7 had more than
one indicator for screening and management available.
In addition to the indicators themselves, data were
often available on contact between a woman and the
health system during either antenatal care (one or four
antenatal care visits) or during care at birth (either
facility delivery or skilled birth attendance) (Table 2,
population data). For example, data were available for
caesarean section, ANC visits, skilled birth attendance,
and facility delivery from 70, 73, 75, and 75 countries,
respectively, with at least 75 % of these data from
2010–2015.
The facility-based instruments did collect data on
process indicators for many of the Essential Interven-
tions, but were more focused on readiness to deliver
antenatal care and emergency obstetric care; outcome
indicators were rarely included. The availability of
supplies was universally available from the survey
instruments for only four interventions, while the sup-
plies available for seven interventions were not tracked
in any of the instruments. Similar results were
observed for training relative to the Essential Interven-
tions and for whether the intervention was actually
performed. In addition, eight of the WHO Essential
Interventions were not able to be tracked at facilities
by any of the identified facility survey instruments
(Table 2, facility data).
Compilation and expert assessment
A total of 216 indicators were assembled across the fol-
lowing areas: 107 for preconception and antenatal care; 53
for childbirth and postpartum care; and 56 for care for
newborns and small and ill babies. Of these, 122 were
sourced or modified from existing indicators identified in
instruments from available data sources and 94 were de-
veloped by the eRegistries technical team. Indicators were
subsequently independently reviewed by evaluators. Re-
sponse rates across the evaluation rounds were 23, 21, and
25 (68 %, 60 %, and 57 % respectively), with 31 evaluators
in total participating (see Fig. 1 for distribution of
countries represented). Some evaluators agreed to score a
second set of indicators within the same round.
Indicators for preconception/periconceptual care and
antenatal care generally fulfilled the criteria ‘Action
focused’, Important’, and ‘Simple and valued’. Indicators
were less often deemed ‘Operational’ and ‘Feasible’, par-
ticularly for cause-specific mortality where capacity in
some regions to accurately attribute death to specific
conditions was considered lacking. The lack of availabil-
ity of resources and skilled health personnel in LMIC
settings was also seen as a barrier to the utility of many
indicators. Figure 2 presents evaluation data for the
treatment outcome indicator ‘Malaria-specific stillbirth
rate (per 100,000 births)’, which represents the typical
pattern of results received across evaluation rounds.
Indicators for childbirth care and postpartum care
(of the mother) interventions were deemed to meet (or
probably meet) all criteria by the majority of evalua-
tors. Indicators consistently scored lowest on the cri-
teria ‘Feasible’ and (less often) ‘Operational’, with
variable evaluations on the criteria ‘Action focused’,
‘Important’, and ‘Simple and valued’. Panel members
raised concerns around the feasibility of data collection
in LMIC where many births occur at home and where
follow-up is difficult. Difficulty accurately attributing
cause of death for specific conditions/complications
was again raised for all settings, but particularly in
LMIC. The feasibility and appropriateness of the ma-
ternal near-miss indicators introduced in this round
was questioned. A number of panel members thought
that health workers may lack understanding and/or ap-
preciation of the concept of near-miss, and some antic-
ipated the indicators may lead to data manipulation in
order to conceal what may be perceived as suboptimal
care. Some of the indicators associated with the HIV
interventions appeared too complex and needed clari-
fication and simplification.
Indicators around newborn care received more mixed
evaluations across the criteria, again, with feasibility
a clear impediment. Evaluations varied on the cri-
teria ‘Action focused’, ‘Important’, and ‘Simple and
valued’.
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Table 2 Current status of use of global indicators for the 45 included WHO Essential Interventions
Intervention Population data
(Percent of the population)
Facility data





















NA NA – – 5 of 7i 4 of 7 3 of 7
Family planninga – 22 % 31 % 4 % 5 of 7 4 of 7 3 of 7
Prevention and management of STIs
and HIV
– – – – 1 of 7 2 of 7 2 of 7
Safe abortion services – – 26 % – 4 of 7 2 of 7 4 of 7
Post-abortion care – – – – 2 of 7 2 of 7 2 of7
Antenatal care visit (1+) (contact) NA NA 84 % – NA NA NA
Antenatal care visit (4+) (contact) NA NA 57 % – NA NA NA
Essential packageb NA NA – – 4 of 7 4 of 7 3 of 7
Iron and folic acid supplementationc NA NA 26 % – 4 of 7 2 of 7 3 of 7
Tetanus toxoid vaccinationd NA NA 81 % – 4 of 7 0 of 7 3 of 7
Prevention of malaria with prophylactic
antimalarials
NA NA 27 % – 4 of 7 4 of 7 4 of 7
Prevention of malaria with ITN NA NA 37 % –
Smoking cessation during pregnancy – – – – 0 of 7 0 of 7 0 of 7
Detection and management
of syphilise
44 % 2 % 37 % – 5 of 7 5 of 7 5 of 7
Detection and management
of HIV (including PMTCT)f
– 3 % 67 % 17 % 6 of 7 4 of 7 6 of 7
Calcium supplementation for deficient
women in pregnancy
– – – – 1 of 7 0 of 7 0 of 7
Aspirin for pre-eclampsia prevention – – 1 of 7 0 of 7 0 of 7
Antihypertensive drugs for hypertension
in pregnancy
– – 3 of 7 0 of 7 1 of 7
Anticonvulsants (i.e., MgSO4) – – – – 7 of 7 2 of 7 3 of 7
External cephalic version – – – – 0 of 7 0 of 7 0 of 7
Induction of labor after pPRoM – – – – 0 of 7 0 of 7 1 of 7
Antibiotics for pPRoM – – – – 6 of 7 0 of 7 3 of 7













Table 2 Current status of use of global indicators for the 45 included WHO Essential Interventions (Continued)
Childbirth and
postpartum care
Skilled attendant at birth (contact) NA NA 66 % – NA NA NA
Facility delivery (contact) NA NA 63 % – NA NA NA
Social support during childbirth NA NA – – 0 of 7 0 of 7 0 of 7
Prophylactic antibiotics for cesarean
section
– – – – 5 of 7 1 of 7 3 of 7
Cesarean section – – 10 % – 3 of 7 2 of 7 4 of 7
Uterotonics for prevention of
hemorrhage
NA NA – – 8 of 8 5 of 8 6 of 8
Active management of the 3rd stage
of labor
NA NA – – 8 of 8 5 of 8 4 of 8
Induction at ≥ 41 weeks of gestation – – – – 0 of 7 0 of 7 1 of 7
Uterotonics for treatment of hemorrhage – – – – 8 of 8 2 of 8 5 of 8
Manual removal of the placenta – – – – 4 of 7 2 of 7 3 of 7
Initiation or continuation of HIV therapy
for HIV positive womenf (see above)α
– 3 % 67 % 17 % 6 of 7 4 of 7 6 of 7
Family planning and advice for
contraceptivesa (See above)α
– 22 % 31 % 4.00 % 5 of 7 4 of 7 3 of 7
Screen for and initiate or continue
antiretroviral therapy for HIVf (see above) α
– 3 % 67 % 17 % 6 of 7 4 of 7 6 of 7
Treat maternal anemiag – 40 % – – 0 of 7 0 of 7 0 of 7
Detect and manage postpartum sepsis – – – – 0 of 7 1 of 7 1 of 7
Newborns and small
and ill babies
Immediate thermal care – – – – 4 of 7 3 of 7 2 of 7
Promotion and support for early
Initiation of breastfeeding
NA NA 50 % – 1 of 7 4 of 7 3 of 7
Promotion and provision of hygienic
cord and skin care
NA NA – – 1 of 7 2 of 7 2 of 7
Neonatal resuscitation – – – – 6 of 7 3 of 7 6 of 7
Newborn Immunizationh NA NA 91 %/37 % – 2 of 7 0 of 7 1 of 7
Presumptive antibiotic therapy for
newborns at risk of bacterial infection
– – – – 2 of 7 1 of 7 2 of 7
Case management of neonatal sepsis,
meningitis, and pneumonia
– – – – 2 of 7 1 of 7 2 of 7
Initiation of ART in babies born to HIV
infected motherf (see above)α













Table 2 Current status of use of global indicators for the 45 included WHO Essential Interventions (Continued)
Kangaroo mother care for preterm and
for <2000 g babies
– – – – 1 of 7 1 of 7 1 of 7
Extra support for feeding the small and
preterm baby
– – – – 0 of 7 0 of 7 1 of 7
Prophylactic and therapeutic use of
surfactant
– – – – 0 of 7 0 of 7 1 of 7
Continuous positive airway pressure
(CPAP) for RDS
– – – – 0 of 7 0 of 7 1 of 7
Management of newborns with Jaundice – – – – 1 of 7 0 of 7 1 of 7
aScreening outcome indicator is unmet need for family planning; coverage indicator is contraceptive prevalence rate; management outcome is total fertility rate
bShould include measurement of blood pressure, anaemia, and identification of pre-eclampsia
cindicator is percent of women taking 90+ days of iron supplementation, available from household surveys
dSource: data.unicef.org; defined as percent of neonates protected at birth from tetanus infection
eSource: WHO Global observatory; 56 countries with Process indicator, 62 with outcome, 31 with coverage able to be estimated
fScreening outcome is modelled results of HIV prevalence, available from aidsinfoonline.org/devinfo/libraries/aspx/Home.aspx; coverage indicator is percent of population in need with HIV managed, available from
data.unicef.org; Management indicator is Paediatric transmission rate, available from data.unicef.org
gAnaemia prevalence in any woman of reproductive age, available from household surveys
hSource: data.unicef.org; BCG and Hepatitis B birth dose vaccinations
iThe number of survey instruments which cover this topic out of all the survey instruments which could have covered this topic. Thus 7 survey instruments were identified for all topics except for haemorrhage for














Response to feedback and refinement within the eRegistries
technical team
Amendments were made to a number of indicator titles,
data points and definitions based on feedback from
the expert panel (see Additional file 4 for examples).
Amendments to indicators and definitions involved better
operationalisation of key terms (e.g. breastfeeding counsel-
ling, ‘successful’ ECV, continuous support during labour).
Indicators were reworded and redefined to improve direct
measurability (e.g. Antenatal detection of breech presenta-
tion was revised to ‘Proportion of pregnant women who
have presentation of baby checked by skilled birth
attendant at or after 37 weeks of gestation’). Indicators
and data points were also altered in some cases to ensure
applicability in different settings; for example, the in-
dicator measuring the proportion of women with postpar-
tum haemorrhage who received therapeutic oxytocin was
deemed too restrictive for settings where other uterotonics
such as misoprostol are used.
Following refinements, there were a total of 193
unique indicators: 93 addressing preconception and
antenatal care; 53 addressing childbirth and postpartum
care; and 47 addressing care for newborns and small















Fig. 1 Countries represented by expert panel across scoring rounds (N = 31)
Fig. 2 Evaluation for prophylactic antimalarial for preventing malaria in pregnancy treatment outcome indicator #3: Malaria-specific stillbirth rate
(per 100,000 births) (n = 4)
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indicators including definitions, data points and sources
(full indicator reports are available from the authors on
request).
A series of meetings of the eRegistries technical team
was held to review the updated indicators to ensure
consistency in nomenclature across indicators and their
data points, numerators and denominators. We estab-
lished a set of definitions to guide the use of denomina-
tors and data points to ensure consistency across the
indicator suite (Additional file 6).
Display of utilisation of the indicators
Figure 3 demonstrates the association between statis-
tical power, sample size and the prevalence of an in-
dicator. As shown, there is likely to be insufficient
power when measured at a clinic or district levels to
determine differences in rare outcomes such as mor-
tality, while adequate power would exist at national
levels. In small clinics, there is likely to be sufficient
power to measure differences in common manage-
ment indicators, such as skilled birth attendance and
iron supplementation.
Discussion
We used the Donabedian framework [11] to deter-
mine the indicators required to successfully monitor
the WHO Essential Interventions. This framework en-
compasses the intuitive relationship between three re-
lated concepts: first, the structures of health care are
defined as the physical and organisational aspects of
care settings (e.g., facilities, equipment, personnel);
second, the processes of patient care in order to
Fig. 3 Correlation between indicator prevalence, statistical power and population size. Not all available indicators should be used equally when
evaluating different levels of a health system. The selection of evaluation indicators should vary based on whether there is adequate power to
measure a significant change and whether the outcome is modifiable by that level of the health system, a different set of indicators is appropriate for
quality improvement at clinics than for national planning purposes. The figure indicates that a typical clinic (e.g. a facility with 200 births per year) only
has adequate power to identify large differences in relatively frequent events, such as process indicators for interventions needed universally (i.e. SBA,
immediate breastfeeding). Districts (10,000 births annually) have the ability to monitor relatively rare process indicators (management of maternal
haemorrhage) as well as relatively common impacts (i.e. stillbirths) while populations the size of a typical country (e.g. 500,000 births annually) are
needed to monitor rare outcomes (i.e. cause specific maternal mortality ratios or early neonatal mortality rates). All levels of the health system should
be aware of the full range of indicators, but should only be evaluated on those which are appropriate at that specific level
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improve patient health; and, third, the well-known
concepts of outcomes of medical care. Four groups of
indicators were needed to clearly identify areas for
quality improvement: process indicator/s for screen-
ing/risk identification (i.e. the proportion of screening
tests/risk identification measures that were per-
formed); outcome indicator/s for screening/risk identi-
fication (i.e. the proportion of women screening
positive/identified as at risk); process indicator/s for
treatment/management (i.e. the proportion of women
treated); and outcome indicator/s for treatment/
management (i.e. the proportion of adverse outcomes
in the population). This work also drew upon health
service ‘bottleneck analyses’ [13, 14], which consider
structural and process factors that influence service
delivery.
Our review of existing household and facility sur-
veys which aredesigned to support national and global
decision making, revealed a large gap in the availabil-
ity of information to support the implementation of
the WHO Essential Interventions, showing a critical
need for improvements in data collection to monitor
these interventions consistently across countries.
Many of the needed indicators cannot be assessed
retrospectively at the population level due to recall is-
sues and lack of medical knowledge. On the other
hand, many of the facility surveys focus narrowly on
the structures of health care delivery. This leaves a
large gap specifically in the arena of process indica-
tors. In addition, the survey results and instruments
evaluated demonstrate that several key interventions
are not being monitored at all, even within the do-
mains of structure or outcome. For example, there is
no population level information to monitor antibiotics for
pPRoM, while family planning activities and prevention
and treatment of HIV are monitored relatively compre-
hensively. Although smoking cessation is recommended,
none of the facility survey instruments included questions
to assess this intervention and only one survey included
questions on structural components to support the avail-
ability and utilization of calcium supplementation. These
large gaps indicate that there is insufficient information
available to guide countries and programs as they at-
tempt to ensure the availability of the WHO Essential
Interventions in their facilities and for their populations.
There is a minimum of information to support the de-
cision making at any of facility, national or global levels.
It is this gap which the current indicator selection at-
tempts to address.
We assembled a set of clearly defined process and
outcome indicators, with a comprehensive suite of syn-
ergistic and consistent data points for effective measure-
ment, for the 45 WHO Essential Interventions spanning
preconception to newborn care, which can be collected
from routine sources or facility surveys. Further, the
eRegistries indicator evaluation tool makes a unique
contribution to the metrics field, as it enables a priori
assessment of the ‘likely’ or ‘potential’ utility of novel in-
dicators. In our literature review, we found a paucity of
information on indicator evaluation approaches to that
did not rely on post-hoc review of the data generated by
the indicator.
Feasibility in LMIC (informed by the direct experi-
ences of many expert panel members) was a clear con-
cern throughout the indicator evaluation process.
Indeed, household surveys would, for example, not be
able to assess all indicators proposed. Not all denomina-
tors would be measureable, making the results uninter-
pretable, and unattended home births would skew the
numbers dramatically. However, the purpose of the
proposed indicators is to facilitate uniform data collec-
tion in the presence of health workers documenting
their actual work in a setting that accommodates an
eRegistry or similarly-structured system for prospective
data collection. Therefore, that a service (e.g. induction
of labour for prolonged pregnancy) is not offered in a
particular setting does not necessarily pose a problem
for feasibility of data collection inherent in the indica-
tor itself.
This study has several limitations. Although the expert
panel consisted of members from low, middle and high-
income settings, it did not include health systems spe-
cialists or programme managers, who may offer add-
itional expertise. A legitimate feasibility problem may be
posed by the use of cause-specific morbidity and mortal-
ity indicators, due to difficulty ascertaining cause of
death, especially in some low-resource settings. This un-
derscores the critical need for a quality, international,
standardised cause of death classification system for ma-
ternal and perinatal mortality. Consistent application of
the WHO’s International Classification of Diseases for
Maternal Mortality and Perinatal Mortality (ICD-MM
and ICD-PM) [23] may therefore enhance the utility of
some of the indicators.
The indicators presented here are important for
understanding the interplay between the patient and the
health system, and how health system improvement
can be achieved. The indicators presented do not re-
present an exhaustive list of the necessary indicators for
all population-based or facility-based assessments, and
should not be used in isolation. While these indicators are
designed for use in settings with a functional health sys-
tem collecting information on care-provision provision
across the continuum of care, they are developed to min-
imise erroneous estimates in settings where a significant
proportion of individuals do not attend a health system,
and thus may not be included in denominators of the
population. For example, where pregnancies in need of
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ANC are used in the denominator for ANC indicators, we
define an eligible pregnancy as “a woman having one
documented ANC visit (unless the ANC visit is only for ter-
mination of pregnancy), OR any data documenting a preg-
nancy outcome or infant at any point of care” (Additional
file 6). This means that in an eRegistry setting tracking in-
dividuals, only individuals who are not in contact with any
professional care provider from the health system through
pregnancy, childbirth, post-partum care, newborn and
infant care including vaccinations, will be missed as a
population denominator.
In addition, these indicators are not a comprehensive
set of indicators required to monitor a health system.
These indicators are those that can be collected through
an eRegistry and are necessary to address the 45 WHO Es-
sential Interventions. Additional indicators for other com-
ponents of a health system are clearly needed, as the
WHO list does not include all interventions delivered by a
health system (e.g. the management of diabetes in preg-
nancy). Other data sources, and potentially other indica-
tors, should be utilized to understand the full continuum
of availability, coverage and quality of community based
activities, not only as stand-alone activities but also linked
with facility-based activities.
The development of the eRegistries indicators is part
of a global push to increase quality of care through an
increased focus on measurement. The WHO recently
published their vision for quality of care for maternal
and newborn health [24], drawing partially upon the
frameworks discussed in this paper, and have begun de-
veloping metrics to address quality of care. Two global
action agendas, (‘Strategies toward Ending Preventable
Maternal Mortality’ (EPMM) and the ‘Every Newborn
Action plan’ (ENAP)) are also in the process of finalizing
consensus metrics to increase the global ability to meas-
ure quality of care. These strategies contributed to the
development of UN Secretary General’s Global Strategy
for Women’s Children’s and Adolescents’ Health (2016–
2030) which addresses relevant issues across the health
in order to attain the related SDGs.
The eRegistries indicators contribute to the Indicator
and Monitoring Framework [25] developed to support
monitoring progress in implementation of the Global
Strategy for Women’s Children’s and Adolescents’
Health (2016–2030) [26]. ‘Quality indicators’ are needed
for monitoring healthcare, whether for internal quality
improvement or for external accountability [27]. The
eRegistries technical team developed this set of indica-
tors to provide guidance on core indicators that should
be part of routine information systems to ensure that a
comparable, consistent and comprehensive set of indica-
tors is available to countries as they attempt to link their
new electronic data collection systems with the older
household survey-based data sources. Importantly, any
implementation of an eRegistry must adhere to national
guidelines, and include careful development of custo-
mised indicators and associated data points. This set of
indicators should serve as a warehouse or library of indi-
cators for use whenever possible to ensure comparability
with WHO standards for care. These indicators should
not be used en masse to monitor all levels of a health
system equally. Different indicators will have different
uses as well as different characteristics, dependent on
the size of the population which is being monitored and
the type of decisions needed at various levels of the
health system. As evidenced from the graphic display of
the association between power, sample size and indicator
prevalence, the selected indicators can vary dramatically
in usefulness for the different levels of the health system.
Indicators relevant for individual clinics will typically re-
late to those activities being undertaken at the clinic for
all women. Small sample sizes related to rare complica-
tions and outcomes will make some indicators less useful
for understanding practices within specific individual
clinics, but collection of these data is nonetheless highly
relevant for monitoring of public health at the national-
level.
Conclusions
With many countries in transition from paper to electronic
data collection, more effort needs to be made to collect
useable data at the point of data creation, and to minimise
issues with recall, transcription and bias. The development
of this suite of indicators can be used to support the imple-
mentation of eRegistries and other data platforms, to
ensure that data are utilised to support evidence-based
practice, facilitate measurement and accountability, and
improve maternal and child health outcomes.
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